CorMedix Inc. (CRMD)

CorMedix Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	43.72	43.27	53.45	42.1	16.53
Short-Term Investments	32.39	15.64	12.15	4.44	11.98
Cash & Cash Equivalents	76.11	58.92	65.6	46.54	28.51
Cash Growth	29.18%	-10.19%	40.95%	63.25%	60.21%
Receivables	0	0	0.05	0	0
Inventory	2.11	0	0	0.14	0.34
Other Current Assets	1.24	0.63	0.82	1.49	0.5
Total Current Assets	79.45	59.55	66.47	48.18	29.35
Property, Plant & Equipment	2.51	2.38	2.37	1.13	0.13
Long-Term Investments	0.1	0.1	0.1	0	0
Total Long-Term Assets	2.61	2.49	2.48	1.13	0.13
Total Assets	82.06	62.04	68.95	49.31	29.48
Accounts Payable	4.28	2.2	2.21	1.13	1.02
Deferred Revenue	0	0	0	0	0
Current Debt	0.15	0.13	0.12	0.11	0
Other Current Liabilities	6.97	3.97	3.01	2.92	4.8
Total Current Liabilities	11.4	6.31	5.35	4.16	5.83
Long-Term Debt	0.52	0.67	0.8	0.92	0
Total Long-Term Liabilities	0.52	0.67	0.8	0.92	0
Total Liabilities	11.92	6.98	6.15	5.09	5.83
Total Debt	0.67	0.8	0.92	1.03	0
Debt Growth	-16.80%	-13.14%	-10.56%	21926.79%	-99.92%
Retained Earnings	-321.7	-275.36	-245.66	-217.45	-195.42
Comprehensive Income	0.09	0.08	0.09	0.1	0.1
Shareholders' Equity	70.14	55.06	62.8	44.22	23.65
Net Cash / Debt	75.44	58.11	64.67	45.51	28.5
Net Cash / Debt Growth	29.81%	-10.14%	42.12%	59.65%	144.26%
Net Cash Per Share	1.48	1.44	1.72	1.59	1.18
Working Capital	68.05	53.24	61.12	44.02	23.52
Book Value Per Share	1.38	1.37	1.67	1.55	0.98

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).